Press release
29.06.2016 To the attention of interested persons EMA press release: Adempas not for use in patients with pulmonary hypertension caused […]
29.06.2016 To the attention of interested persons EMA press release: Adempas not for use in patients with pulmonary hypertension caused […]
23.06.2016 To the attention of all wholesale distributors of medicinal products Please be advised that the national Czech authority has […]
15.06.2016 To the attention of Marketing Authorisation Holders (MAHs)/MAH representatives EMA press release on Periodic Safety Update Report (PSUR) repository […]
15.06.2016 To the attention of interested persons Considering that, lately information related to the lack of efficacy of generics, explicitly […]
15.06.2016 To the attention of interested persons EMA press release: Single, central platform now mandatory for all periodic safety update […]
30.05.2016 To the attention of interested persons EMA press release: Improving safety of first-in-human clinical trials download document …
25.05.2016 To the attention of interested persons Following appearance in the media of the Notification on the outcome of the […]
18.05.2016 To the attention of interested persons EMA press release on inhibitor development in previously untreated patients with severe haemophilia […]
16.05.2016 To the attention of interested persons The National Agency for Medicines and Medical Devices states the following, in accordance […]
05.05.2016 To the attention of interested persons EMA press release on start of a review on the conduct of studies […]